(NASDAQ: IRTC) Irhythm Holdings's forecast annual revenue growth rate of 16.84% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.07%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.5%.
Irhythm Holdings's revenue in 2026 is $747,138,000.On average, 18 Wall Street analysts forecast IRTC's revenue for 2026 to be $28,873,732,390, with the lowest IRTC revenue forecast at $27,672,195,253, and the highest IRTC revenue forecast at $29,823,521,966. On average, 18 Wall Street analysts forecast IRTC's revenue for 2027 to be $33,480,163,360, with the lowest IRTC revenue forecast at $31,676,888,152, and the highest IRTC revenue forecast at $35,516,119,240.
In 2028, IRTC is forecast to generate $38,683,161,720 in revenue, with the lowest revenue forecast at $36,000,870,640 and the highest revenue forecast at $40,783,751,120.